Simethicone and Silica for Infant Colic: Clinical Trial

Simethicone and Silica Dioxide for Infant Colic: Gruppo FarmaImpresa Clinical Trial on Efficacy and Benefits Infant colic is characterized by excessive crying and irritability in otherwise healthy infants, with a variable prevalence worldwide. This condition can be associated with a higher risk of maternal depression and shaken baby syndrome. Behavioral and dietary interventions, such as…

Gruppo FarmaImpresa receives first MDR certifications

Gruppo FarmaImpresa is among the first Italian companies to obtain MDR certifications for some of its substance-based medical devices As a reminder, the new Regulation (EU) 2017/745 or MDR (Medical Device Regulation) is the European medical device regulation that defines regulations and constraints that all manufacturers and distributors must comply with in order to place…